$7.5 Million Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying
Benzinga
Published Dec 20, 2022 12:25
Updated Dec 20, 2022 13:40
$7.5 Million Bet On This Financial Services Stock? Check Out These 3 Stocks Insiders Are Buying
Benzinga - Although US stocks closed lower on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
- The Trade: Victory Capital Holdings, Inc. (NASDAQ: VCTR) Chairman and CEO Craig David Brown acquired a total of 60,000 shares an average price of $26.97. To acquire these shares, it cost around $1.62 million.
- What’s Happening: Piper Sandler recently maintained Victory Capital with an Underweight and lowered the price target from $29 to $27.
- What Victory Capital Does: Victory Capital Holdings Inc is an independent investment management firm.
- The Trade: Williams Rowland Acquisition Corp. (NYSE: WRAC) Director, Co- Chief Executive Officer, David B. Williams acquired a total of 741,921 shares at an average price of $10.20. To acquire these shares, it cost around $7.56 million.
- What’s Happening: The company’s stock dropped around 2% over the past month.
- What Williams Rowland Acquisition Does: Williams Rowland Acquisition Corp is a blank check company.
Read Also: CNN Fear & Greed Index Moves To 'Fear' Zone Amid Recession Concerns
h2 Masimo /h2- The Trade: Masimo Corporation (NASDAQ: MASI) Director, CEO and Chairman of the Board) Joe Kiani bought a total of 7,040 shares at an average price of $144.79. To acquire these shares, it cost around $1.02 million.
- What’s Happening: BTIG recently upgraded Masimo from Neutral to Buy and announced $180 price target.
- What Masimo Does: Masimo is an Irvine, California-based medical device business that focuses on noninvasive patient monitoring.
Read the original article on Benzinga
Get The App
Written By: Benzinga
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.